Editorial: risk of loss of response to anti TNF alpha in patients with inflammatory bowel diseases - the longer the less? Authors' reply: risk of loss of response to anti TNFα in patients with inflammatory bowel diseases - the longer the less? Authors' reply

Johannes P D Schultheiss, Remi Mahmoud, Herma H Fidder, Bas Oldenburg

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)246-246
Number of pages1
JournalAlimentary Pharmacology & Therapeutics
Volume55
Issue number2
DOIs
Publication statusPublished - Jan 2022

Cite this